Identification of serum microRNAs for cardiovascular risk stratification in dyslipidemia subjects

Int J Cardiol. 2014 Mar 1;172(1):232-4. doi: 10.1016/j.ijcard.2013.12.214. Epub 2014 Jan 8.

¹ Department of Clinical Laboratory, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, China.
² Jiangsu Engineering Research Centre for microRNA Biology and Biotechnology, State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, China.
³ Department of Clinical Laboratory, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, China. Electronic address: [email protected].
⁴ Jiangsu Engineering Research Centre for microRNA Biology and Biotechnology, State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, China. Electronic address: [email protected].
⁵ Department of Clinical Laboratory, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, China. Electronic address: [email protected].

No abstract available

Keywords: Biomarker; Cardiovascular disease; Dyslipidemia; MicroRNA; Quantitative reverse-transcription PCR; Risk stratification.

Publication types